🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Golden Cross Emerges For Morgan Stanley Stock On Q4 Earnings Beat Despite Analyst Downgrades

Published 19/01/2024, 15:31
© Reuters.  Golden Cross Emerges For Morgan Stanley Stock On Q4 Earnings Beat Despite Analyst Downgrades
MS
-

Benzinga - by Surbhi Jain, .

Morgan Stanley (NYSE:MS) stock beat on EPS and revenue as it reported its fourth-quarter earnings on Jan. 16.

Buoyed by positive sentiments around the company, the stock just made a Golden Cross on the technical price charts.

On Jan. 18, the 50-day SMA for Morgan Stanley stock crossed over the 200-day SMA, indicating bullish sentiments overriding bearish ones.

Being a momentum indicator, the golden cross indicates that prices are continuously increasing—gaining momentum. It is interpreted by analysts and traders as signaling a definitive upward turn in a market.

Per its earnings report, Morgan Stanley’s Q4 EPS of $1.13 beat consensus by 22.83%, while revenue of $12.90 billion beat consensus by 10.89%. The beat came in despite a profit drop.

Morgan Stanley’s Q4 profit dropped to $1.5 billion (compared to $2.2 billion in Q4 2022) due to higher wealth management costs and a $249 million regulatory settlement.

Related: Morgan Stanley’s Earnings: Q4 Beats Revenue Estimates Despite Profit Decline

Analysts, who reviewed the stock after the earnings report either downgraded or maintained their ratings on the stock, with three of four analysts cutting their price target for Morgan Stanley stock.

  • Oppenheimer’s Chris Kotowski maintained Outperform while reducing his price target to $106.
  • BMO Capital’s James Fotheringham maintained Outperform rating with a price target of $107.
  • David Konrad of Keefe, Bruyette & Woods downgraded he stock from Outperform to Market Perform while reducing price target from $102 to $91 a share.
  • JP Morgan’s Kian Abouhossein downgraded from Overweight to Neutral, and the price target from$94 to $87.
The Golden Cross just made should infuse confidence among Morgan Stanley investors.

Now Read: 3 Key Priorities For Investment Banks In 2024: Report Details Strategies For Success

Latest Ratings for MS

DateFirmActionFromTo
Jan 2022Odeon CapitalDowngradesBuyHold
Jan 2022UBSMaintainsBuy
Jan 2022BarclaysMaintainsOverweight
View More Analyst Ratings for MS

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.